News

Novo Nordisk A/S: Ozempic® reduces the risk of heart attack, stroke and death by 23% compared to dulaglutide in the first head-to-head real-world study

Ozempic® (once-weekly injectable semaglutide) was associated with a 23% reduced risk of heart attack, stroke and death in people with type 2 diabetes and cardiovascular disease on Medicare versus ...

Frontline Canadians: Why Pilots are Flying into the Congo's Conflict Zones

On International Day of Peace, Mission Aviation Fellowship Canada honours the nation’s legacy of peacekeeping and ...